Alzheimer’s therapy passes another important test: Drug candidate PRI-002 has successfully completed Phase I of clinical research On 2019-05-14 The Alzheimer drug candidate PRI-002 has successfully completed Phase I of clinical research involving healthy volunteers. When administered daily over […]
Protein BRCA1 as a stress coach On 2019-03-22 Anyone who has ever studied the molecular basis of breast cancer will probably have heard of the abbreviation BRCA1 — […]
New therapy for amyotrophic lateral sclerosis successfully tested on mice On 2019-02-06 A team from Université Laval and the CERVO Brain Research Centre has demonstrated the efficacy in mice of a new […]
New study explains why genetic mutations cause disease in some people but not in others: Large genomic datasets and CRISPR offer new insights into disease risk On 2018-08-21 Researchers at the New York Genome Center (NYGC) and Columbia University have uncovered a molecular mechanism behind one of biology’s […]
SMURF1 provides targeted approach to preventing cocaine addiction relapse On 2018-08-15 A class of proteins that has generated significant interest for its potential to treat diseases, has for the first time, […]
Neurodegenerative disease found in monkeys: Discovery could accelerate development of new gene therapies for Batten disease On 2018-07-28 OHSU scientists have discovered a naturally occurring disease in monkeys that mimics a deadly childhood neurodegenerative disorder in people — […]
New assay reveals biophysical properties that allow certain proteins to infect others On 2018-07-06 Scientists at the Stowers Institute for Medical Research have identified a physical basis for the spread of corrupted proteins known […]